Summary In a previous study we found that aromatic amines, particularly 4-aminobiphenyl, formed haemoglobin adducts at higher concentrations in the blood of smokers compared to non-smokers. We re-analyse here data on haemoglobin adducts of 14 aromatic amines in order to ascertain if the inter-individual variability left unexplained by tobacco smoking could be attributed to differences in individual metabolic patterns. For this purpose we computed residuals from analysis of variance in order to adjust for individual smoking habits (type and amount of tobacco). Residuals were correlated within two clearly distinct groups: one formed by binuclear compounds (4-aminobiphenyl, 3-aminobiphenyl and 2-naphthylamine) and the other formed by all other (i.e. mononuclear) compounds. Within each group, highly statistically significant correlation coefficients were found, whereas compounds belonging to one group were not correlated to compounds in the other group. These results can be interpreted as a suggestion that two different metabolic pathways exist, one for binuclear and one for mononuclear arylamines, and that inter-individual differences in such pathways can explain part of inter-individual variability in adduct levels. This interpretation is consistent with recent animal experiments suggesting that there are different enzyme systems for the two classes of compounds.
In a previously published paper, Bryant et al. (1988) reported that the quantity of haemoglobin adducts of 3-aminobiphenyl (3-ABP) and 4-aminobiphenyl (4-ABP) was related to the number of cigarettes smoked and, for 4-ABP, to the kind of tobacco (air-or flue-cured). However, the amount and type of tobacco smoked left unexplained a considerable proportion of inter-individual variability of haemoglobin adducts of the 14 investigated arylamines, including 3-ABP, 4-ABP and 2-naphthylaine (2-NA).
4-ABP and 2-NA are well known bladder carcinogens, in both humans and experimental animals (IARC, 1987) . Of the 14 investigated arylamines, three were binuclear: 3-ABP and 4-ABP are formed by two benzene rings and 2-NA is a naphthalene derivative; all the others have a single aromatic ring.
Here we re-analyse the same data set in order to ascertain whether the unexplained residual variability might be related to differences in individual metabolic patterns. If individual metabolic differences were responsible for part of the so far unexplained inter-individual variability in haemoglobin adducts and if chemically similar substances had, at least in part, common metabolic pathways, then one would expect the concentrations of adducts of similar amines to be correlated in the same individual, after allowing for amount and type of tobacco smoked. In other words, if the hypothesis is correct, after allowing for smoking habits, subjects showing high levels of 4-ABP adducts should also have high levels of 3-ABP adducts and subjects showing low levels of 4-ABP should also have low levels of 3-ABP.
Materials and methods
Subjects and materials included in the present analysis are the same described in the previous report, which also describes laboratory procedures (Bryant et al., 1988) .
Blood samples (10 ml) were collected from male volunteers: 25 non-smokers, 18 smokers of air-cured, black tobacco and 43 smokers of flue-cured, blond tobacco (three of these had also smoked a limited number of black tobacco cigarettes in the recent past). All lived in the city of Turin. Blood samples were blindly analysed for haemoglobin adducts formed by 14 aromatic amines, using gas chromatography-mass spectrometry. Table I shows the distribution of smokers by type of tobacco and number of cigarettes smoked the day before blood sampling (three smokers of unfiltered cigarettes were excluded). We excluded non-smokers and smokers belonging to cells where only one subject was represented (those who smoked 3, 8, 10, 12, 16, 17 a way that they explain as much of the total variation in the data as possible, with as few of these factors as possible (Kleinbaum & Kupper, 1978 Table II ).
Results Table II reports the proportion of inter-individual variability (among smokers) for haemoglobin adducts of single aromatic amines explained by smoking habits in terms of R2: from 91 to 46% of variability, depending on the substance, is left unexplained by the kind of tobacco and number of cigarettes smoked the day before blood collection. Table III shows the correlation matrix between the residuals of the 14 aromatic amines, measured as log (adduct concentration). Residuals of 3-ABP, 4-ABP and 2-NA (the binuclear amines) show high reciprocal correlation coefficients, but low correlation with residuals of the other, mononuclear, amines (except P-toluidine). In contrast, the residuals of all other substances are in general highly intercorrelated but they show independence from residuals of the first group of substances. Nearly all the mono-mono and bi-bi correlation coefficients are above 0.4 and nearly all the mono-bi correlations are below 0.2. Of the correlations between different binuclear amines all three are statistically significant (P <0.05), and of the correlations between different mononuclear amines, 49 out of 54 are statistically significant, whereas of the 33 correlations between one monoand one binuclear amine, only two are significant.
In Table IV , PCA (see Statistical analysis) shows that the first factor explains 49% of total variance and is related to all substances but 3-ABP, 4-ABP and 2-NA; the second factor explains a further 16% of total variance and is related to 3-ABP, 4-ABP and 2-NA, whereas coefficients for all other amines (except P-toluidine) are negative or close to zero.
We repeated the analysis including blond tobacco smokers only (36 subjects) and results did not change. (Guengerich, 1988) or N-acetyltransferase (Schulte, 1988) , involved in the activation or deactivation of carcinogenic compounds are known to be genetically determined, in the sense that genotypic polymorphisms exist in human populations. Acquired inter-individual differences are also possible, due to enzyme induction.
In the case of aromatic amines, it is plausible that different Weights of residuals ofeach substance in the first four factors, see text for definition of factors and for the meaning ofweights. aSee Table 11 for the meaning of abbreviations. .o ..= metabolic pathways exist for mono-and binuclear compounds respectively. In particular, a single cytochrome P-450 is considered now to be responsible for N-hydroxylation of binuclear aromatic amines (Butler et al., 1990) . Experiments have been conducted to determine the inducibility of covalent binding by continuous adminstration of either 2,6-dimethylaniline or 2-acetylaminofluorene to rats (Short & Hardy, 1989 ). An increase in covalent binding in the target organ was seen for 2,6-dimethylaniline while a decrease in the target organ was observed for 2-acetylaminofluorene. This can be interpreted as a difference in the type of metabolism induced by the monocyclic versus the policyclic aromatic amines and supports the hypothesis that there are different enzyme systems for these two classes of compounds.
The following alternative hypotheses can be considered. 2. Exposure to sources of aromatic amines other than tobacco smoking. However, none of the subjects was clearly exposed to aromatic amines for occupational or other reasons other than smoking. In addition, in order to justify this interpretation some subjects should have been exposed to mononuclear amines only and others to binuclear amines only, which is totally implausible.
3. Measurement errors might be reciprocally correlated within, but not between, the two groups of substances. This, however, seems to be a very implausible explanation of the findings, considering that many correlation coefficients are higher than 0.5 and a few are higher than 0.9. In order to justify a correlation coefficient of 0.5, variance due to measurement error should be as large as the true variance of adduct concentrations, and to justify a correlation coefficient of 0.9 it should be nine times as large. Clearly this is very unlikely.
In conclusion, none of the considered alternative hypotheses seems to be able to explain completely the findings, even if they could account for part of them. On the basis of the present results it is plausible that inter-individual metabolic differences affect internal levels of exposure to carcinogens. Such metabolic patterns might be relevant to the individual risk of cancer. However, this suggestion needs to be verified in further epidemiological and experimental studies. 
